Screening chemical inhibitors for alpha-amylase from leaves extracts of Murraya koenigii (Linn.) and Aegle marmelos L
- PMID: 32745070
- DOI: 10.1515/jcim-2019-0345
Screening chemical inhibitors for alpha-amylase from leaves extracts of Murraya koenigii (Linn.) and Aegle marmelos L
Abstract
Objectives: Aqueous leaves extracts of Murraya koenigii (M. koenigii) and Aegle marmelos (A. marmelos) were prepared and effect of the extracts on inhibiting alpha-amylase playing essential roles on converting starch into glucose have been examined using in vitro assays.
Methods: Alpha amylase inhibitory assay was used to asses the in vitro antidiabetic activity of the extracts. Gas chromatography-mass spectrometry (GC-MS) analysis was performed to identify the volatile molecules of the extracts. Identified molecule were converted as ligand and docked against human pancreatic α-amylase (0.95 Å; PDB ID: 5U3A) using Autodock tool.
Results: The data analyzes suggested that the alpha-amylase inhibition potential of the extract obtained from M. koenigii was stronger than that of the A. marmelos at low concentrations (<1 mg/mL), whereas both the extracts depicted similar inhibition effects on the enzyme at high concentration (>1 mg/mL). The phytochemicals present in both the plant extracts were identified by using their respective GC-MS data and the data analyzes revealed that the extracts of M. koenigii and A. Marmelos seemed to consist of about 20 and 24 diverse chemical molecules, respectively. Through the molecular docking studies, azulene of M. koenigii and hydroxycyclodecadiene of A. marmelos showed higher binding affinity on alpha-amylase.
Conclusions: Concentration-dependent alpha-amylase inhibition effects of the extracts were observed and M. koenigii contains more alpha-amylase inhibitory effects due to the presence of azulene. This is primary lead to find out the better anti diabetic natural based drug to the society after clinical trial.
Keywords: Aegle marmelos; HTVS; Murraya koenigii; alpha-amylase; anti-diabetic.
© 2020 Walter de Gruyter GmbH, Berlin/Boston.
References
-
- Porte, D. Clinical importance of insulin secretion and its interaction with insulin resistance in the treatment of type-2 diabetes mellitus and its complications. Diabetes Metabol Res Rev 2001;17:181–8. https://doi.org/10.1002/1520-7560.
-
- Wild, S, Roglic, G, Green, A, Sicree, R, King, H. Global prevalence of diabetes estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047–53. https://doi.org/10.2337/diacare.27.5.1047.
-
- Franz, MJ. Protein controversies in diabetes. Diabetes Spectr 2000;13:132–41.
-
- Gannon, MC, Nuttall, JA, Damberg, G, Gupta, V, Nuttall, FQ. Effect of protein ingestion on the glucose appearance rate in people with type-2 diabetes. J Clin Endocrinol Metab 2001;86:1040–7. https://doi.org/10.1210/jcem.86.3.7263.
-
- Wolever, TMS, Katzmanrelle, L, Jenkins, AL, Vuksan, V, Josse, RG, Jenkins, DJA. Glycemic index of 102 complex carbohydrate foods in patients with diabetes. Nutr Res 1994;14:651–9. https://doi.org/10.1016/s0271-5317(05)80201-5.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous